- I WANT SO MUCH TO LIVE explores the pioneering efforts of Genentech and the many individuals who came together to develop Herceptin, the world's first 'targeted therapy' for breast cancer. In this original documentary, award-winning filmmaker Elizabeth Holder presents a rarely seen portrait of drug development. From early scientific discoveries in the lab to testing the drug in patients, this film captures the emotional and compelling story of what it took personally and professionally to advance the project from scientific curiosity to lifesaving medicine.—Anonymous
- Through historical documents and moving personal accounts, this film chronicles the nearly two-decade journey from the identification of the HER2 gene to the FDA approval of Herceptin. As the clinical development unfolds, the company faces challenges and conflicts that threaten the future of the drug. The process also takes on new urgency when women with breast cancer and their advocates get early signs the drug may be working. Seeing the potential of the experimental medicine and out of other treatment options, they unite in their demands for access. Despite their differences, Genentech, physicians, breast cancer patients and their advocates must work together if Herceptin is going to gain FDA approval so that all women with HER2-positive breast cancer have access.
Contribute to this page
Suggest an edit or add missing content